Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinkui Zexie Decoction vs betahistine for benign paroxysmal positional vertigo
ChiCTR2100048603Phase 3Not yet recruiting
- Sponsor
- China Academy of Chinese Medical Sciences
- Start
- Aug 2021
- Countries
- 1
01
Overview
Phase 3, randomised trial of Jinkui Zexie Decoction in benign paroxysmal positional vertigo (BPPV) (2 arms), sponsored by China Academy of Chinese Medical Sciences. Primary endpoint: Vertigo Disability Rating Scale score (DHI, Chinese version). Planned start Aug 2021; status: not yet recruiting.
02
Drugs
Jinkui Zexie Decoction
03
Conditions
benign paroxysmal positional vertigo (BPPV)
Beyond the preview
Go deeper on ChiCTR2100048603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048603.